# Study to Assess the Safety and Pharmacokinetics of AVD275 Injection in Patients With Osteoarthritis of the Knee

> **NCT07338266** · PHASE1 · RECRUITING · sponsor: **Avidence Therapeutics** · enrollment: 15 (estimated)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** AVD275 Intra-articular Injection

## Key facts

- **NCT ID:** NCT07338266
- **Lead sponsor:** Avidence Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-22
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07338266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07338266, "Study to Assess the Safety and Pharmacokinetics of AVD275 Injection in Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07338266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*